Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

American Heart Association: Patient-centered imaging is at the ‘heart’ of patient-centered care

Patient-centered care isn’t achievable without patient-centered imaging. Upon this obvious yet easily overlooked principle, the American Heart Association is urging heart doctors across various subspecialties to talk to patients about radiation risks before imaging their chests.

American Heart Association: Patient-centered imaging is at the ‘heart’ of patient-centered care

Patient-centered care isn’t achievable without patient-centered imaging. Upon this obvious yet easily overlooked principle, the American Heart Association is urging heart doctors across various subspecialties to talk to patients about radiation risks before imaging their chests.

Thumbnail

Integrin PET imaging during therapy may not tell the whole story

Anti-angiogenesis drugs have been making waves as treatments for some cancers. Researchers have been developing new biomarkers to map the progress of these therapies, including those that target integrin expression. However, a new study published online yesterday in the Journal of Nuclear Medicine indicates that integrin expression imaging may not provide a mirror image of the impact of peptide therapy as it occurs.

Angsty women in mid-life may be at higher risk for Alzheimer’s

Yet another risk factor for neurodegenerative disease has cropped up in recent studies: Worry among older women. Research conducted at the University of Gothenburg in Sweden provided a score on the scale of neuroticism for 800 women in mid-life and evaluated any potential links to Alzheimer's. Those who peaked on the anxiety scale were two times as likely to develop the disease.

Novel amino-acid PET tracer may increase specificity for certain cancers

A first-in-human study of (D)-18F-fluoromethyltyrosine (D-18F-FMT), a tyrosine derivative, is being evaluated for diagnostic imaging of non-small cell lung cancer (NSCLC) as well as head and neck squamous cell cancers (HNSCC). Results show that it could provide some differentiation in a space dominated by FDG, according to a study published Sept. 25 in the Journal of Nuclear Medicine.

Thumbnail

Johns Hopkins to host cyber-security summit

In light of recent data theft at retailers and other businesses, as well as amid fears of additional data breaches as the healthcare environment migrates to the digital world, Johns Hopkins information security experts have helped organize a conference to inform top executives about the growing risks of digital break-ins, how to reduce these risks, and how to manage the aftermath of a data breach.

A breakdown of genetic biomarkers

An analysis of genetic biomarkers from Genetic Engineering & Biotechnology explains the differences between predictive and prognostic characteristics and provides a perspective on the current landscape of research and development for a number of key assays.

Flurpiridaz PET MPI data reveal lower dose than conventional SPECT

Myocardial perfusion imaging (MPI) with PET and F-18 flurpiridaz may reduce radiation dose while still providing comparable image quality to SPECT, the current standard, according to a study presented at the recent American Society of Nuclear Cardiology (ASNC) Annual Scientific Session held in Boston from Sept 18-21.